Evaluation of the utility of brain slice methods to study brain penetration

被引:55
作者
Becker, S [1 ]
Liu, XR [1 ]
机构
[1] Pfizer Global Res & Dev, Pharmacokinet, Groton, CT 06340 USA
关键词
D O I
10.1124/dmd.105.007914
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
The objective of this study was to evaluate the utility of brain tissue slices to determine the effect of plasma and brain tissue nonspecific binding on the brain-to-plasma ratio (K-p). Mouse or rat brain slices ( 400 mu m) were prepared using a McIlwain tissue chopper ( Surrey, UK) and incubated with 1 mu g/ml of compound at 37 degrees C either in a physiological buffer to determine the buffer-to-slice concentration ratio, i.e., unbound fraction in brain tissue (f(u, slice)), or in plasma to determine the slice-to-plasma concentration ratio (C-slice/C-plasma). The unbound fraction in plasma, f(u,plasma), was determined using equilibrium dialysis. In vitro-in vivo correlation of the brain-to-plasma ratio was examined for 13 and eight model compounds in mice and rats, respectively. C-slice/C-plasma and f(u,plasma)/f(u,slice) predicted the K-p in rats, and C-slice/C-plasma predicted the K-p in FVB mice for non-P-glycoprotein substrates within 3-fold but overpredicted K-p for P-glycoprotein substrates by more than 3-fold. However, C-slice/C-plasma predicted the K-p in mdr1a/1b knockout mice for both non-P-glycoprotein and P-glycoprotein substrates. Our present study demonstrates that a brain slice method can be used to differentiate whether a compound having a low Kp is due to the effect of low nonspecific binding to brain tissue relative to plasma proteins or because of efflux transport at the blood-brain barrier.
引用
收藏
页码:855 / 861
页数:7
相关论文
共 17 条
[1]
Chen JJ, 2003, REC RES DEV PLANT S, V1, P31
[2]
COLLINGRIDGE GL, 1994, J NEUROSCI METH, V59, P5
[3]
DAVSON H, 1995, PHYSL CSF BLOOD BRAI
[4]
The impact of P-glycoprotein on the disposition of drugs targeted for indications of the central nervous system: Evaluation using the MDR1A/1B knockout mouse model [J].
Doran, A ;
Obach, RS ;
Smith, BJ ;
Hosea, NA ;
Becker, S ;
Callegari, E ;
Chen, CP ;
Chen, X ;
Choo, E ;
Cianfrogna, J ;
Cox, LM ;
Gibbs, JP ;
Gibbs, MA ;
Hatch, H ;
Hop, CECA ;
Kasman, IN ;
LaPerle, J ;
Liu, JH ;
Liu, XR ;
Logman, M ;
Maclin, D ;
Nedza, FM ;
Nelson, F ;
Olson, E ;
Rahematpura, S ;
Raunig, D ;
Rogers, S ;
Schmidt, K ;
Spracklin, DK ;
Szewc, M ;
Troutman, M ;
Tseng, E ;
Tu, MH ;
Van Deusen, JW ;
Venkatakrishnan, K ;
Walens, G ;
Wang, EQ ;
Wong, D ;
Yasgar, AS ;
Zhang, CH .
DRUG METABOLISM AND DISPOSITION, 2005, 33 (01) :165-174
[5]
Fichtl B., 1991, ADV DRUG RES, P117
[6]
Determination of diffusion and partition coefficients of propofol in rat brain tissue:: implications for studies of drug action in vitro [J].
Gredell, JA ;
Turnquist, PA ;
MacIver, MB ;
Pearce, RA .
BRITISH JOURNAL OF ANAESTHESIA, 2004, 93 (06) :810-817
[7]
Kakee A, 1996, J PHARMACOL EXP THER, V277, P1550
[8]
Influence of nonspecific brain and plasma binding on CNS exposure: Implications for rational drug discovery [J].
Kalvass, JC ;
Maurer, TS .
BIOPHARMACEUTICS & DRUG DISPOSITION, 2002, 23 (08) :327-338
[9]
Kusuhara H, 1997, J PHARMACOL EXP THER, V283, P574
[10]
Liu XR, 2005, CURR OPIN DRUG DISC, V8, P505